Clinical trial

Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis

NCT03940235

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-10-01

PhasePHASE2

Study timeline

Study start (actual)2019-10-01Date precision: day

Registry last updated2023-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Oligometastatic Prostate Cancerunresolved

Interventions

Androgen deprivation therapy (ADT)DRUG

SBRTRADIATION

Sponsors & collaborators

European Institute of Oncologylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03940235 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.